These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32075830)

  • 1. Economic evaluation of the OSAC randomised controlled trial: oral corticosteroids for non-asthmatic adults with acute lower respiratory tract infection in primary care.
    Moure-Fernandez A; Hollinghurst S; Carroll FE; Downing H; Young G; Brookes S; May M; El-Gohary M; Harnden A; Kendrick D; Lafond N; Little P; Moore M; Orton E; Thompson M; Timmins D; Wang K; Hay AD
    BMJ Open; 2020 Feb; 10(2):e033567. PubMed ID: 32075830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Oral Prednisolone on Symptom Duration and Severity in Nonasthmatic Adults With Acute Lower Respiratory Tract Infection: A Randomized Clinical Trial.
    Hay AD; Little P; Harnden A; Thompson M; Wang K; Kendrick D; Orton E; Brookes ST; Young GJ; May M; Hollinghurst S; Carroll FE; Downing H; Timmins D; Lafond N; El-Gohary M; Moore M
    JAMA; 2017 Aug; 318(8):721-730. PubMed ID: 28829884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can oral corticosteroids reduce the severity or duration of an acute cough, and the associated National Health Service and societal costs, in adults presenting to primary care? Study protocol for a randomised controlled trial.
    Downing HE; Carroll F; Brookes ST; Hollinghurst S; Timmins D; Orton E; Wang K; Kendrick D; Little P; Moore MV; Harnden A; Thompson M; May MT; Hay AD;
    Trials; 2015 Mar; 16():78. PubMed ID: 25885677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Christian MT; Webb NJ; Woolley RL; Afentou N; Mehta S; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
    Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.
    Chalmers JR; Wojnarowska F; Kirtschig G; Mason J; Childs M; Whitham D; Harman K; Chapman A; Walton S; Schmidt E; Godec TR; Nunn AJ; Williams HC
    Health Technol Assess; 2017 Mar; 21(10):1-90. PubMed ID: 28406394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral prednisolone for acute lower respiratory tract infection in clinically unrecognised asthma: an exploratory analysis of the Oral Steroids for Acute Cough (OSAC) randomised controlled trial.
    Hawkey S; Young GJ; Little P; Moore M; Hay AD
    BJGP Open; 2020 Dec; 4(5):. PubMed ID: 33144370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics for lower respiratory tract infection in children presenting in primary care: ARTIC-PC RCT.
    Little P; Francis NA; Stuart B; O'Reilly G; Thompson N; Becque T; Hay AD; Wang K; Sharland M; Harnden A; Yao G; Raftery J; Zhu S; Little J; Hookham C; Rowley K; Euden J; Harman K; Coenen S; Read RC; Woods C; Butler CC; Faust SN; Leydon G; Wan M; Hood K; Whitehurst J; Richards-Hall S; Smith P; Thomas M; Moore M; Verheij T
    Health Technol Assess; 2023 Jun; 27(9):1-90. PubMed ID: 37436003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
    Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
    Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
    Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
    Lewis H; Adamson J; Atherton K; Bailey D; Birtwistle J; Bosanquet K; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hargate R; Hewitt C; Holmes J; Keding A; Lilley-Kelly A; Maya J; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Overend K; Pasterfield M; Richards D; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Ziegler F; Gilbody S
    Health Technol Assess; 2017 Feb; 21(8):1-196. PubMed ID: 28248154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT.
    Kapoor M; Storrar W; Balls L; Brown TP; Mansur A; Hedley E; Jones T; Roberts C; Shirkey B; Dutton S; Luengo-Fernandez R; Little M; Dewey A; Marshall S; Fogg C; Boughton K; Rahman N; Yu LM; Bradding P; Howarth P; Chauhan AJ
    Health Technol Assess; 2019 Jun; 23(29):1-140. PubMed ID: 31232684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenaline to improve survival in out-of-hospital cardiac arrest: the PARAMEDIC2 RCT.
    Perkins GD; Ji C; Achana F; Black JJ; Charlton K; Crawford J; de Paeztron A; Deakin C; Docherty M; Finn J; Fothergill RT; Gates S; Gunson I; Han K; Hennings S; Horton J; Khan K; Lamb S; Long J; Miller J; Moore F; Nolan J; O'Shea L; Petrou S; Pocock H; Quinn T; Rees N; Regan S; Rosser A; Scomparin C; Slowther A; Lall R
    Health Technol Assess; 2021 Apr; 25(25):1-166. PubMed ID: 33861194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a primary healthcare intervention to treat male lower urinary tract symptoms: the TRIUMPH cluster randomised controlled trial.
    Cochrane M; Drake MJ; Worthington J; Frost J; Cotterill N; Fader M; McGeagh L; Hashim H; Lane A; Macaulay M; MacNeill S; Rees J; Ridd MJ; Robles LA; Sanderson E; Taylor G; Taylor J; Noble S
    BMJ Open; 2024 Jan; 14(1):e075704. PubMed ID: 38296301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a patient-centred approach to managing multimorbidity in primary care: a pragmatic cluster randomised controlled trial.
    Thorn J; Man MS; Chaplin K; Bower P; Brookes S; Gaunt D; Fitzpatrick B; Gardner C; Guthrie B; Hollinghurst S; Lee V; Mercer SW; Salisbury C
    BMJ Open; 2020 Jan; 10(1):e030110. PubMed ID: 31959601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
    Bosanquet K; Adamson J; Atherton K; Bailey D; Baxter C; Beresford-Dent J; Birtwistle J; Chew-Graham C; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hamilton J; Hargate R; Hewitt C; Holmes J; Keding A; Lewis H; McMillan D; Meer S; Mitchell N; Nutbrown S; Overend K; Parrott S; Pervin J; Richards DA; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Gilbody S
    Health Technol Assess; 2017 Nov; 21(67):1-252. PubMed ID: 29171379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial).
    Pickard R; Lam T; Maclennan G; Starr K; Kilonzo M; McPherson G; Gillies K; McDonald A; Walton K; Buckley B; Glazener C; Boachie C; Burr J; Norrie J; Vale L; Grant A; N'dow J
    Health Technol Assess; 2012 Nov; 16(47):1-197. PubMed ID: 23199586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.